aPTT

Activated Partial Thromboplastin Time

Coagulation

What is Activated Partial Thromboplastin Time?

Activated partial thromboplastin time (aPTT) is a coagulation test that measures the time it takes for blood to form a clot through the intrinsic and common coagulation pathways. The test evaluates the function of clotting factors XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen). In the laboratory, a blood sample is mixed with a phospholipid reagent, a contact activator (such as kaolin, silica, or ellagic acid), and calcium chloride, and the time to clot formation is measured in seconds.

The aPTT is one of the most commonly ordered coagulation tests, used both for screening bleeding disorders and for monitoring anticoagulation therapy. It is particularly sensitive to deficiencies in the intrinsic pathway factors (VIII, IX, XI, XII) and is the standard test for monitoring unfractionated heparin therapy. When used in conjunction with the prothrombin time (PT/INR), which evaluates the extrinsic pathway, the two tests together can help localize which part of the coagulation cascade is abnormal, guiding further diagnostic workup for bleeding or clotting disorders.

Why It Matters

The aPTT is essential for evaluating the body's ability to form blood clots properly. A prolonged aPTT may indicate a bleeding disorder such as hemophilia A (factor VIII deficiency) or hemophilia B (factor IX deficiency), von Willebrand disease, or the presence of an inhibitor like a lupus anticoagulant. In clinical practice, aPTT is critical for monitoring patients on unfractionated heparin therapy to ensure the dose is therapeutic—too little heparin increases clotting risk, while too much increases bleeding risk. The aPTT also serves as a preoperative screening tool to identify unsuspected coagulation abnormalities before surgical procedures.

Normal Reference Ranges

Group	Range	Unit
Adults	25–35	seconds
Therapeutic heparin range	60–80	seconds
Newborns	31–54	seconds

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High aPTT Levels Mean

Common Causes

Hemophilia A (factor VIII deficiency) or B (factor IX deficiency)
von Willebrand disease
Unfractionated heparin therapy
Lupus anticoagulant (antiphospholipid syndrome)
Disseminated intravascular coagulation (DIC)
Liver disease (impaired clotting factor production)
Vitamin K deficiency (affects common pathway factors)
Factor XI or XII deficiency
Specific factor inhibitors (antibodies)

Possible Symptoms

Easy bruising
Prolonged bleeding from cuts or dental procedures
Spontaneous nosebleeds (epistaxis)
Heavy menstrual bleeding
Joint bleeding (hemarthrosis)—classic in hemophilia
Blood in urine or stool
Excessive bleeding after surgery or trauma

What to do: A prolonged aPTT requires further investigation with a mixing study—mixing the patient's plasma with normal plasma to determine if the prolongation corrects (suggesting factor deficiency) or persists (suggesting an inhibitor). Based on results, specific factor levels, von Willebrand factor testing, or lupus anticoagulant testing may be ordered. If on heparin, the dose may need adjustment. Severe bleeding may require factor replacement, fresh frozen plasma, or cryoprecipitate.

What Low aPTT Levels Mean

Common Causes

Extensive cancer (increased procoagulant activity)
Acute phase response (increased factor VIII as an acute phase reactant)
Early disseminated intravascular coagulation
Elevated factor VIII levels
Technical or sample issues

Possible Symptoms

Usually no direct symptoms from shortened aPTT
May be associated with increased thrombotic risk in some contexts

What to do: A shortened aPTT is less commonly clinically significant but may indicate a hypercoagulable state. Evaluate for thrombotic risk factors, particularly if the patient has a history of blood clots. Check factor VIII levels, as elevated factor VIII is both an acute phase reactant and an independent thrombotic risk factor. Clinical correlation is essential.

When Is aPTT Testing Recommended?

As a preoperative coagulation screening test
When a bleeding disorder is suspected
To monitor unfractionated heparin therapy
When evaluating unexplained bruising or prolonged bleeding
As part of a DIC workup
When lupus anticoagulant or antiphospholipid syndrome is suspected

Frequently Asked Questions

A mixing study is performed when the aPTT is prolonged to distinguish between a clotting factor deficiency and the presence of an inhibitor. The patient's plasma is mixed 1:1 with normal pooled plasma, and the aPTT is repeated. If the aPTT corrects to normal, the patient has a factor deficiency (the normal plasma provides the missing factor). If the aPTT remains prolonged, an inhibitor is present—either a lupus anticoagulant or a specific factor inhibitor (antibody). This distinction is crucial because treatment strategies differ dramatically.

aPTT and PT/INR evaluate different parts of the coagulation cascade. The aPTT tests the intrinsic pathway (factors XII, XI, IX, VIII) and the common pathway (X, V, II, fibrinogen). The PT/INR tests the extrinsic pathway (factor VII and tissue factor) and the common pathway. Used together, they help pinpoint where a coagulation problem lies. A prolonged aPTT with normal PT suggests an intrinsic pathway problem (like hemophilia). A prolonged PT with normal aPTT suggests a factor VII issue. Both prolonged suggests a common pathway or multiple factor problem.

This is one of the most counterintuitive aspects of coagulation medicine. Lupus anticoagulant is an antibody that binds to phospholipids used in the aPTT test, artificially prolonging the clotting time in the test tube—hence the name "anticoagulant." However, in the body, these antibodies promote clotting by activating endothelial cells, platelets, and complement, creating a prothrombotic state. Patients with lupus anticoagulant are at increased risk for venous and arterial thrombosis, not bleeding, despite the paradoxically prolonged aPTT.

Related Biomarkers

PT/INRProthrombin Time FibFibrinogen D-DD-Dimer

Want your aPTT levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.